- Presentations
- 4
- Markets
- 1
Strensiq is a brand of Asfotase alfa marketed by Alexion Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Asfotase alfa
- Brand owner
- Alexion Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 18 mg/0.45 mL injection, 28 mg/0.7 mL injection, 40 mg/1 mL injection, 80 mg/0.8 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Strensiq 18 mg/0.45 mL injectionSubcutaneous Cold chain | Alexion Pharmaceuticals | US FDA | Available on request |
| Strensiq 28 mg/0.7 mL injectionSubcutaneous Cold chain | Alexion Pharmaceuticals | US FDA | Available on request |
| Strensiq 40 mg/1 mL injectionSubcutaneous Cold chain | Alexion Pharmaceuticals | US FDA | Available on request |
| Strensiq 80 mg/0.8 mL injectionSubcutaneous Cold chain | Alexion Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Strensiq
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.